How do I find out if I qualify for a recurrent transformed chronic lymphocytic leukemia study in Ohio?

Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.

Do I have to live in Ohio to take part?

Not necessarily. These studies have a site in Ohio, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.

Does it cost anything to join a recurrent transformed chronic lymphocytic leukemia trial?

Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.

Clinical trials · Ohio

Recurrent Transformed Chronic Lymphocytic Leukemia clinical trials in Ohio

We’re tracking 4 recruiting recurrent transformed chronic lymphocytic leukemia studies with a site in Ohio — including Phase 1, Phase 1/Phase 2 and Phase 2 studies, each written for real people, not researchers.

Recruiting studies in Ohio

NCT05873712RecruitingPhase 2
Zanubrutinib plus CAR-T for Richter syndrome
This Phase 2 trial tests whether a combination of zanubrutinib (an oral medicine) and CAR-T cell therapy can treat Richter syndrome, a type of lymphoma that develops in people with CLL/SLL. It may help shrink tumors and improve outcomes after the disease comes back or doesn’t respond to prior treatment.
Columbus, OhioAges 18 years+
NCT04679012RecruitingPhase 2
Polatuzumab plus chemotherapy for Richter’s transformation
This trial studies whether polatuzumab added to chemotherapy can improve outcomes in people whose CLL/SLL has transformed into a type of aggressive lymphoma called DLBCL. It may help shrink tumors and control the disease after this transformation.
Columbus, OhioAges 18 years+
NCT05418088RecruitingPhase 1
CAR T-cell therapy for hard-to-treat B-cell cancers
This Phase 1 study tests lab-made immune cells (CAR T-cells) that target CD19, CD20, and/or CD22 in people with certain relapsed or refractory B-cell cancers. It may help by attacking cancer cells that still carry these targets, but eligibility is very specific and includes prior treatments and health/lab requirements.
Columbus, OhioAges 2 years+
NCT06536049RecruitingPhase 1/Phase 2
Epcoritamab plus ibrutinib for relapsed or refractory aggressive B-cell lymphoma
This trial tests a combination of two drugs – epcoritamab (a type of immunotherapy that helps your immune system attack lymphoma cells) and ibrutinib (a targeted pill that blocks signals that help cancer grow). It is for people with aggressive B-cell lymphoma that has come back or not responded to at least 2 prior treatments.
Columbus, OhioAges 18 years+

Recurrent Transformed Chronic Lymphocytic Leukemia trials by city in Ohio

Columbus

Where these studies are running in Ohio

Institutions with a site for the recruiting recurrent transformed chronic lymphocytic leukemia studies listed above.

The Ohio State University Wexner Medical Center · 4 studies
Nationwide Children's Hospital

What taking part in a recurrent transformed chronic lymphocytic leukemia study involves

A screening visit first

Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.

Care at a nearby site

Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.

You stay in control

Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.

The team decides eligibility

Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.

Common questions

Are there recurrent transformed chronic lymphocytic leukemia clinical trials in Ohio?: Yes. We're currently tracking 4 recruiting recurrent transformed chronic lymphocytic leukemia studies with a site in Ohio, each rewritten in plain language so you can see what it's testing and who it's for.
How do I find out if I qualify for a recurrent transformed chronic lymphocytic leukemia study in Ohio?: Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
Do I have to live in Ohio to take part?: Not necessarily. These studies have a site in Ohio, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
Does it cost anything to join a recurrent transformed chronic lymphocytic leukemia trial?: Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.

Not the right time?

New recurrent transformed chronic lymphocytic leukemia studies open in Ohio regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.

Get told when a study that fits you opens

Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.